Facet-related spinal pain for non-specific low back pain pose considerable challenge for radiologists and clinicians in finding the right set of interventional tools.
Facet Joint Injections Market: Overview
Facet-related spinal pain for non-specific low back pain pose considerable challenge for radiologists and clinicians in finding the right set of interventional tools. The reason has to do with nonspecific clinical features and radiological findings. For patients suffering with facet-joint pain, the condition is debilitating and often leads to physical deconditioning, restricted daily motion, and muscle spasm. In the backdrop of the substantial burden of facet-joint pain, the facet joint injections market has made a swift emergence. A significant proportion of the target population is 30–50 years, which adds to the morbidity. The facet joint injection market has seen the growing traction of imaging-guided injections in outpatient procedures. The injectable consists mainly of local anesthetic and steroids.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=80233
Key application segments in the facet joint injections market are cervical facet joints, thoracic facet joints, and lumbar facet joints. In the evolution process, a number of spinal injections have been tested for their effect in reducing pain intensity and improving rehabilitation. There is an unmet need for more research on different injectable and associated outpatient procedures with the goal of improving diagnostic accuracy, safety, and reproducibility.
Request for Analysis of COVID-19 Impact on Facet Joint Injections Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=80233
Facet Joint Injections Market: Key Trends
The study on the facet joint injections market offers critical assessment of key growth dynamics, the market scope on major clinical trials, and clinical trends that have substantial industry potential. The research presents a scrutiny of how the competitive landscape is evolving and the various facets of the adoption of the procedures related to facet joint injections.
The drive for the facet joint injections market stems from the demand for improving the outcomes of the current therapeutics and diagnostics. Growing adoption of these injections in outpatient procedures is a key trend boosting the market’s growth.
The epidemiology of facet joint pain is a key underpinning for key research and development in the facet joint injections market. More than two thirds of the population globally suffer from back pain, with chronic pain prevalent in young adults. The high incidence and prevalence of chronic spine pain is a key factor boosting the demand in the facet joint injections market. Though in most cases, episodes in the spinal pain are short-lived but in recent years, the recurrence rate is significant-- 28% to 75%, according to several of the recent studies. The high economic burden of facet joint injections in terms of loss of productivity is a key trend boosting the market.
Pre Book Facet Joint Injections Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=80233<ype=S
The unmet need of diagnosis of spinal symptoms is a key aspect boosting the facet joint injections market. The use of local anaesthetic with prolonged effect and depot steroid preparations is a key trend boosting the market. Technological strides made in imaging-guided intra-articular injection are expanding the avenue in the facet joint injections market. The growing use of high-quality C-arm fluoroscopy in therapeutic interventions in outpatient procedures has bolstered the prospects in the market.
Read more information here:
https://www.transparencymarketresearch.com/facet-joint-injections-market.html
Some of the key players in the facet joint injections market are Sigma-Aldrich, Symbiotec Pharmalab Private Limited, Avik Pharmaceuticals Ltd., Bristol-Myers Squibb Company, Bausch Health Companies Inc., Aspen Pharmacare, Henry Schein Medicalt, Pierrel, and Primex Pharmaceuticals Oy.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453